Craig Hasday
PresidentHasday is president of Frenkel Benefits, an EPIC company, a major independent employee benefit broker.
Hasday is president of Frenkel Benefits, an EPIC company, a major independent employee benefit broker.
Prescription drugs for foreign countries cost a fraction compared to U.S. pricing. Of course they are more attractive but roadblocks remain.
A “Hail Mary” pass is understandable when it comes to treating a seriously ill loved one, but questions remain about reimbursement.
It’s easy to fault the insurance industry, but dealing with the government could be a nightmare. This is why benefit advisers need to step in.
The regulatory environment is one of the toughest in the country and the expansion of PEOs is leading to adverse risk selection.
All three entities have a long-term profit focus, which makes them incentivized to tackle drug price transparency, behavior incentives, technology improvements and more.
The CVS-Aetna deal, for example, would have the potential to take over costly, and previously difficult-to-control, primary care costs.
In addition to a charge for doctor’s services, patients are frequently asked to cover use of the hospital-owned clinic.
A repeal of the ACA requirement in the Senate’s proposal doesn’t get the U.S. closer to much-needed market stability.
Fragile small-group segment will be undermined by liberalization of rules governing association plans.
A close analysis of terms will help to verify critical features such as performance guarantees, TPA service agreements, applicable rebates and more.